Federal regulators plan to authorize an additional dose for seniors and immunocompromised people in the coming weeks, ahead of the introduction of a newly formulated booster later in the year.
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}